Project Grant HT94252410091
Award Date
2/1/24
Completion Date
1/31/26
Dollars Obligated
$384K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cold Spring Harbor, NY 11724, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $518,342 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) for a 3-year period from July 1, 2025 to June 30, 2028. The grant supports research investigating "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." CSHL, a non-profit research institution, will conduct advanced scientific investigations...
The Department of Defense's Defense Health Agency has awarded a $1,344,002 Project Grant to Cold Spring Harbor Laboratory (CSHL) under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, running from August 1, 2024 to July 31, 2028, will fund research to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will leverage its expertise in cancer biology, genomics, and molecular biology to advance this...
This federal Project Grant award, valued at $728,450.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to support research conducted by the Cold Spring Harbor Laboratory (CSHL) in Cold Spring Harbor, NY. The purpose of the award is to investigate "COMMUNICATION BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND NEURONS PROMOTES PANCREATIC CANCER PROGRESSION", with a performance period from July 1, 2025 through June 30, 2028....
The Department of the Army Medical Command has awarded a $1,440,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) for the project "TARGETING HYPOTHALAMIC NEURONS TO ABROGATE STRESS-INDUCED BREAST CANCER GROWTH". The grant period runs from March 1, 2025 to February 29, 2028. Through this award, CSHL will conduct advanced biomedical research focused on transforming healthcare for military service members...
The federal Project Grant award of $1,224,997.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cold Spring Harbor Laboratory (CSHL) to conduct research aimed at "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." This grant, with a performance period from August 1, 2024 to July 31, 2028, will allow CSHL, a renowned non-profit research institution, to leverage its expertise in cancer biology, genomics,...
The University of Pittsburgh - Of The Commonwealth System of Higher Education was awarded a $986,228.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research to identify pathways of progression of acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis. The research aims to transform healthcare for military service members and the broader public by advancing medical...
This $381,312.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at the University of Massachusetts Medical School to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Massachusetts Medical School is the awardee and will be conducting the research through its Grants and...
This federal Project Grant award of $1,665,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating the pathogenesis, diagnosis, and treatment of cardiovascular failure in acute pancreatitis. The award recipient, Mayo Clinic Arizona, will leverage its extensive medical expertise and research capabilities to conduct this project over a period of approximately 4...
The Department of the Army Medical Command awarded $1,394,002 to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2022 for a project grant with a completion date of August 14, 2025. Under this award, Cold Spring Harbor Laboratory and sub-awardees Weill Medical College of Cornell University will explore the relationship between sites of metastatic prostate cancer and the peripheral nerve system. Researchers will analyze human...
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...